A
ORIC icon

AlphaQuest’s Oric Pharmaceuticals ORIC Stock Holding History

AlphaQuest’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,387
Closed -$363K – 1438
2025
Q4 		$363K Buy
44,387
+28,887
+186% +$333K 0.02% 1075
2025
Q3 		$186K Sell
15,500
-4,657
-23% -$49K 0.01% 1440
2025
Q2 		$205K Sell
20,157
-22,520
-53% -$151K 0.02% 1117
2025
Q1 		$238K Buy
42,677
+14,242
+50% +$125K 0.03% 901
2024
Q4 		$229K Buy
28,435
+27,381
+2,598% +$251K 0.03% 815
2024
Q3 		$10.8K Sell
1,054
-9,324
-90% -$92.2K ﹤0.01% 1543
2024
Q2 		$73.4K Buy
10,378
+7,440
+253% +$66.6K 0.01% 1007
2024
Q1 		$40.4K Buy
+2,938
New +$34.9K 0.01% 954

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

AlphaQuest's ORIC Position: Q1 2026 in Review

AlphaQuest sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 44,387 shares — an estimated $363K sold.

AlphaQuest first reported a position in ORIC in Q1 2024 and held it in 8 quarters. The position peaked at $363K in Q4 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • AlphaQuest reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 44,387 Oric Pharmaceuticals shares in Q1 2026, an estimated $363K.
  • AlphaQuest first reported a position in Oric Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Oric Pharmaceuticals position peaked at $363K in Q4 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.